ERBB2 and neoplasm: CHMFL-26, which functions as an irreversible kinase inhibitor of several forms of mutated HER2 including L755S and p95HER2, was found to be able to effectively suppress tumor proliferation via the activation of apoptotic pathways both in vitro and in vivo [126].